Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

First U.S. Zika virus transmission reported, attributed to sex

Published 02/02/2016, 22:55
© Reuters. The larvae of Aedes aegypti mosquito are seen inside Oxitec laboratory in Campinas, Brazil
SASY
-
LUMO
-
DJT
-
TWTR
-

By Jon Herskovitz

AUSTIN, Texas (Reuters) - The first known case of Zika virus transmission in the United States was reported in Texas on Tuesday by local health officials, who said it likely was contracted through sex and not a mosquito bite, a day after the World Health Organization declared an international public health emergency.

The virus, linked to severe birth defects in thousands of babies in Brazil, is spreading rapidly in the Americas, and WHO officials on Tuesday expressed concern that it could hit Africa and Asia as well. Zika had been thought to be spread by the bite of mosquitoes of the Aedes genus, so sexual contact as a mode of transmission would be a potentially alarming development.

Dallas County Health and Human Services said it received confirmation of the case in Dallas from the U.S. Centers for Disease Control and Prevention.

The county department said on Twitter (N:TWTR) that the person was infected through sexual contact with someone who had travelled to Venezuela. The person infected did not travel to the South American country, county health officials said.

The Texas Department of State Health Services was slightly more cautious in its assessment, saying in a statement, "Case details are being evaluated, but the possibility of sexual transmission from an infected person to a non-infected person is likely in this case."

County authorities said there were no reports of the virus being locally transmitted by mosquitoes in the Texas county.

A CDC spokesman confirmed the results of a test for Zika infection but said local officials investigated the mode of transmission.

Previously, international health officials had noted one case of possible person-to-person sexual transmission. But the Pan American Health Organization said more evidence was needed to confirm sexual contact as a means of Zika transmission. The medical literature also has one case in which the virus was detected in semen.

The virus has been reported in more than 30 countries and linked to microcephaly, in which babies have abnormally small heads and improperly developed brains.

The Dow Jones transportation average (DJT) ended 2.9 percent lower following news of the first U.S. transmission of the Zika virus.

MONITORING NEEDED

The WHO has said the virus could infect 4 million people in the Americas. It said on Tuesday it launched a global response unit to fight the mosquito-borne virus.

"Most important, we need to set up surveillance sites in low- and middle-income countries so that we can detect any change in the reporting patterns of microcephaly at an early stage," Dr. Anthony Costello said in Geneva. Costello is WHO's director for maternal, child and adolescent health.

Twenty to 30 sites could be established worldwide, mainly in poor countries without robust healthcare systems.

Brazil is the country hardest hit by Zika. In an address to a joint session of Brazil's Congress, President Dilma Rousseff said her government will spare no resources in mobilizing to combat the mosquito that transmits the virus. With no vaccine or treatment for Zika, efforts to curb its spread have focused on eradicating mosquito breeding sites.

Brazil, which has 3,700 suspected cases of microcephaly that may be linked to Zika, is scheduled to host the Olympics in Rio de Janeiro in August.

Rousseff also said Brazil and the United States will enter a partnership to develop a Zika vaccine as soon as possible to stem the spread of the virus.

VACCINE EFFORTS

French drugmaker Sanofi SA (PA:SASY) on Tuesday announced that it has launched a project to develop a vaccine against the virus, the most decisive commitment yet by a major vaccine maker. The company said its Sanofi Pasteur vaccines division would use its expertise in developing vaccines for similar viruses such as yellow fever, Japanese encephalitis and dengue.

Other companies also joined the race on Tuesday to develop a vaccine. The University of South Australia said it was working on a Zika vaccine with Australian biotech Sementis Ltd.

U.S. drug developer NewLink Genetics Corp (O:NLNK) said it has started a project to develop Zika treatment options.

Experts have said a Zika vaccine for widespread use is months if not years away.

Costello said the Aedes mosquitoes that carry the Zika virus "are present ... through Africa, parts of southern Europe and many parts of Asia, particularly South Asia." Africa and Asia have the world's highest birth rates.

WHO Director-General Margaret Chan said on Monday it was "strongly suspected but not yet scientifically proven" that Zika causes microcephaly.

The first Irish cases of Zika virus have been detected in two people with a history of travelling to a country affected by the mosquito-borne infection, the Health Service Executive of Ireland said.

Chilean health officials said they have confirmed three cases in Chile of people infected with the Zika virus, all of whom were infected while travelling elsewhere in Latin America.

© Reuters. The larvae of Aedes aegypti mosquito are seen inside Oxitec laboratory in Campinas, Brazil

An Australian state health service said two Australians were diagnosed with the virus after returning from the Caribbean, confirming the first cases of the virus in the country this year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.